This news article was originally written in Spanish. It has been automatically translated for your convenience. Reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace a human translator. The original article in Spanish can be viewed at Las Mañanas de la Innovación analizan el valor económico de la biotecnología en la industria farmacéutica y agroalimentaria
The morning of the innovation analyzed the economic value of biotechnology in the pharmaceutical and agri-food industry
02/07/2007
July 2, 2007
The morning of the innovation, forum for discussion and communication between the research world and the company, organized by the Fundació Catalana per a the Recerca i la Innovació (FCRI), the Chamber of Commerce of Barcelona and the Centre for innovation and business development (CIDEM) of the Generalitat de Catalunyaheld its ninth session on Tuesday, 12 June, entitled "Biotechnology as emerging economic sector".
Biotechnology is currently one of the emerging economic sectors at the international level and also in Catalonia. While the scientific production in this area has been important for years now matches, in addition, a notable financial translation in creation of new products and companies in the service of citizens. Large international clusters of sector bio, which has successfully developed significant programmes of work and promotion, have led to expedite the translation of biotechnology in economic value for the pharmaceutical industry, mainly, but also for the agri-food.
The content of the mornings of innovation gave to learn about the latest technologies that currently work technological institutes, research groups and Catalan companies in a particular sector and its practical application in the industrial fabric of the country to increase their competitiveness. The introduction of advances provided by the research shows the way to provide a better service, quality and price, and strengthen the competitive advantages of our businesses in a global market.
The Act included five presentations:
- The role of clusters in the biotechnology environment. Montserrat Vendrell, Director of the Bioregion of Catalonia (BIOCAT)
- The technology transfer in biotechnology. Pere Condom, director of the Science Park and technological-UdG
- The financing of biotechnology companies: peculiarities, challenges and trends. Josep M. Echarri, Chief Financial Officer of Oryzon Genomics
- Impact of biotechnology in the pharmaceutical industry. Olga Fidalgo, Corporate Director of business development and licensing of the Group Ferrer, S.A.
- New genomic technologies. An opportunity for the agri-food sector. Pere Puigdomènech, director of the Center for research in Agrogenómica-CSIC-IRTA_UAB.
Related Companies or Entities
Fundació Catalana per a La Recerca i La Innovació
